JPWO2024143235A5 - - Google Patents

Info

Publication number
JPWO2024143235A5
JPWO2024143235A5 JP2024567767A JP2024567767A JPWO2024143235A5 JP WO2024143235 A5 JPWO2024143235 A5 JP WO2024143235A5 JP 2024567767 A JP2024567767 A JP 2024567767A JP 2024567767 A JP2024567767 A JP 2024567767A JP WO2024143235 A5 JPWO2024143235 A5 JP WO2024143235A5
Authority
JP
Japan
Prior art keywords
compound
solvate
salt
formula
different
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024567767A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2024143235A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2023/046295 external-priority patent/WO2024143235A1/ja
Publication of JPWO2024143235A1 publication Critical patent/JPWO2024143235A1/ja
Publication of JPWO2024143235A5 publication Critical patent/JPWO2024143235A5/ja
Pending legal-status Critical Current

Links

JP2024567767A 2022-12-26 2023-12-25 Pending JPWO2024143235A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022208167 2022-12-26
PCT/JP2023/046295 WO2024143235A1 (ja) 2022-12-26 2023-12-25 甲状腺ホルモン受容体β選択的な甲状腺ホルモンアナログとして有用な化合物

Publications (2)

Publication Number Publication Date
JPWO2024143235A1 JPWO2024143235A1 (https=) 2024-07-04
JPWO2024143235A5 true JPWO2024143235A5 (https=) 2025-10-14

Family

ID=91717871

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024567767A Pending JPWO2024143235A1 (https=) 2022-12-26 2023-12-25

Country Status (3)

Country Link
EP (1) EP4644357A1 (https=)
JP (1) JPWO2024143235A1 (https=)
WO (1) WO2024143235A1 (https=)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007014502A (es) * 2005-05-26 2008-02-07 Metabasis Therapeutics Inc Tiromimeticos para el tratamiento de enfermedades del higado graso.
CN111320609A (zh) * 2018-12-13 2020-06-23 拓臻股份有限公司 一种THRβ受体激动剂化合物及其制备方法和用途
IT201900006923A1 (it) * 2019-05-16 2020-11-16 International Soc For Drug Development S R L Nuovi tiromimetici con uno scaffold bifenilmetano e loro uso
WO2020239076A1 (zh) * 2019-05-29 2020-12-03 南京明德新药研发有限公司 作为甲状腺素受体-β激动剂的哒嗪酮类衍生物及其应用
TW202128668A (zh) * 2019-12-16 2021-08-01 大陸商江蘇恆瑞醫藥股份有限公司 并環類衍生物、其製備方法及其在醫藥上的應用

Similar Documents

Publication Publication Date Title
JP2023523130A5 (https=)
JP2005500311A5 (https=)
JP2009526034A5 (https=)
JP2007530694A5 (https=)
JP2010536889A5 (https=)
JP2004109999A5 (https=)
JP2009523841A5 (https=)
JP2013507423A5 (https=)
RU2008150377A (ru) Новое соединение, обладающее сродством к амилоиду
JP2013523897A5 (https=)
JP2005538057A5 (https=)
JP2010500371A5 (https=)
JP2010524965A5 (https=)
JP2024532768A5 (https=)
JP2004535412A5 (https=)
CA2709861A1 (en) Pharmaceutical compositions
JP2015508068A5 (https=)
JP2019516739A5 (https=)
JP2010520214A5 (https=)
JP2025505745A5 (https=)
JP2023538524A5 (https=)
JP2025507292A5 (https=)
JP2020504434A5 (https=)
JP2021528421A5 (https=)
JPWO2024143235A5 (https=)